NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT06086288 2023-10-17PANDORAFondazione IRCCS Istituto Nazionale dei Tumori, MilanoPhase 2 Not yet recruiting35 enrolled